Phase I trial of short-course chemoradiotherapy followed by chemotherapy as total neoadjuvant therapy for patients with potentially resectable gastric cancer.

Authors

null

Brian D. Badgwell

The University of Texas MD Anderson Cancer Center, Houston, TX

Brian D. Badgwell , Prajnan Das , Naruhiko Ikoma , Mariela A. Blum Murphy , Jenny Jing Li , Jeannelyn Estrella , Bruce D. Minsky , Paul F. Mansfield , Jaffer A. Ajani

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04523818

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 362)

DOI

10.1200/JCO.2024.42.3_suppl.362

Abstract #

362

Poster Bd #

H4

Abstract Disclosures